CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Hydroxychloroquine (placebo)Wiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (3)


Name (Synonyms) Correlation
drug2716 Zinc (Placebo) Wiki 1.00
drug2715 Zinc Wiki 0.41
drug1086 Hydroxychloroquine Wiki 0.10

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D007239 Infection NIH 0.06

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 A Study of Hydroxychloroquine and Zinc in the Prevention of COVID-19 Infection in Military Healthcare Workers (COVID-Milit)

A multicenter randomized clinical trial aiming to assess the efficacy of hydroxychloroquine associated to Zinc compared to hydroxychloroquine, in the prevention of Military Health Professionals Exposed to SARS CoV2 in Tunisia

NCT04377646 Sars-CoV2 COVID19 Drug: Hydroxychloroquine Drug: Hydroxychloroquine (placebo) Drug: Zinc Drug: Zinc (Placebo)
MeSH:Infection

Primary Outcomes

Description: Frequency of confirmed SARS CoV2 infection

Measure: SARS CoV2 infection

Time: At 2 months of follow-up

Secondary Outcomes

Description: Any COVID-19 related symptoms (cough, fever, headache, vomiting, nausea, dyspnea, diarrhea, smell disorder,conjunctivitis, dizziness)

Measure: COVID-19 symptoms description

Time: At 2 months of follow-up

Description: Any adverse event or serious adverse event

Measure: Adverse Events

Time: each month up to 2 months


No related HPO nodes (Using clinical trials)